title: Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab.
authors.forename: E
authors.initials: E
authors.lastname: Sadler
authors.forename: B
authors.initials: B
authors.lastname: Schafleitner
authors.forename: C
authors.initials: C
authors.lastname: Lanschuetzer
authors.forename: M
authors.initials: M
authors.lastname: Laimer
authors.forename: G
authors.initials: G
authors.lastname: Pohla-Gubo
authors.forename: R
authors.initials: R
authors.lastname: Hametner
authors.forename: H
authors.initials: H
authors.lastname: Hintner
authors.forename: J W
authors.initials: JW
authors.lastname: Bauer
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003879:Dermatologic Agents / Q000627:therapeutic use*; D016107:Epidermolysis Bullosa Acquisita / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069283:Rituximab; D017211:Treatment Failure
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D000069283:Rituximab